Hepatitis B virus markers in diabetes mellitus

Area of Science:

• Hepatology
• Endocrinology
• Infectious Diseases

Background:

• Hepatitis B virus (HBV) infection is a global health concern.
• Diabetes mellitus is a prevalent chronic condition with potential links to other health issues.
• Understanding HBV exposure in diabetic populations is crucial for public health.

Purpose of the Study:

• To investigate the prevalence of serum markers for hepatitis B virus (HBV) in diabetic patients.
• To compare HBV marker prevalence between diabetic patients and healthy controls.
• To explore potential correlations between HBV exposure and diabetes characteristics.

Main Methods:

• Serum samples were analyzed for hepatitis B virus (HBV) markers.
• A cohort of 100 diabetic patients (Type I and Type II) was compared with 395 healthy controls.
• Exclusion criteria included history of hepatitis, jaundice, blood transfusions, or hemodialysis.

Main Results:

• A significantly higher prevalence of HBV markers (51%) was observed in diabetic patients compared to controls (25%, P < 0.001).
• The increased prevalence of HBV markers in diabetics was not associated with diabetes duration, age, insulin use, or microvascular complications.
• Even within a relatively high-risk control group (hospital personnel), diabetics exhibited greater HBV exposure.

Conclusions:

• Diabetic patients demonstrate a significantly higher degree of exposure to hepatitis B virus.
• The findings suggest a potential increased proneness to subclinical hepatitis B infection in individuals with diabetes.
• Further research may be warranted to elucidate the mechanisms behind this increased susceptibility.